Israel Defence Minister Naftali Bennett has issues a statement according to which the country has isolated a key coronavirus antibody at its primary biological research centre. This is considered as a “significant breakthrough” towards a possible treatment for Covid-19.
Bennet claimed in the official statement that the “monoclonal antibodies” developed by the Israel Institute for Biological Research (IIBR) “attack the virus and neutralize it” inside the virus carrier’s body.
These monoclonal antibodies are cloned from a single cell, which are much easier to create and use against to polyclonal antibodies which are derived from multiple cells.
According to the news published in Jerusalem Post, IIBR has completed the development phase of the antibody formula and is now looking to manufacture it.
IIBR is a unit that works to counter biological threats against Israel and has been taking the lead in order to develop a treatment and vaccine for the coronavirus, including plasma collection that includes the testing of blood from those who recovered from Covid-19.
Israel was one of the first countries to close its borders and impose increasingly stringent restrictions on movement to catch the spread of the novel coronavirus. It has reported 16,246 cases and 235 deaths due to Covid-19.